Glycoprotein IIB/IIIA inhibitor

Revision as of 09:11, 22 March 2026 by Danbot (talk | contribs) (Add References and Category)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

  • By competing with fibrinogen and von Willebrand factor (vWF) for GP IIb/IIIa binding, GP IIb/IIIa antagonists interfere with platelet cross-linking and platelet-derived thrombus formation
  • Mostly indicated for patients undergoing PCI for ACS

Glycoprotein IIB/IIIA inhibitors

References

Retrieved from "https://www.wikem.org/w/index.php?title=Glycoprotein_IIB/IIIA_inhibitor&oldid=388983"